Skip to main content
Caplight Logo









AlgiSys BioSciences, Inc.

AlgiSys BioSciences, Inc.

Private
Cleveland, OhioHealthcare & Life Scienceshttps://www.algisys.com/

Last Round

Accelerator

May 21, 2025

Total Funding Raised

$2.58M

Company Overview

AlgiSys BioSciences, Inc. is a biotechnology company that produces EPA-rich omega-3 nutritional oils and plant-based protein from microalgae using a proprietary fermentation process.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Sustainable Materials, Clean Manufacturing

Business Model

B2B

Customer Profile

Data as a Service, Services & Consulting

AI Layer

Non-AI

Keywords

microalgaeomega-3EPAheterotrophic fermentationplant-based proteinalgae-based proteinsustainable ingredientsfish-free omega-3aquaculture feedbiotechnologyDHAalternative proteinindustrial fermentationalgae techfood tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

AlgiSys BioSciences, Inc. Comparables

Compare AlgiSys BioSciences, Inc. with similar companies based on industry and business-model similarity.

AlgiSys BioSciences, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Mara Renewables Corporation
78%
Fermentalg S.A.
76%
Evonik Industries AG
75%

AlgiSys BioSciences, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorMay 21, 2025
Early FundingApr 4, 2025
Series BNov 4, 2021
Series AJan 18, 2012

Key People

Founding team and executive leadership

Charles Roe

Chief Technology Officer and Founder

Founding Team

AlgiSys BioSciences, Inc. Investors

Notable investors and investment history

AlgiSys BioSciences, Inc. investors
InvestorRounds
Hatch BlueAccelerator
National Science FoundationGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 22, 2026

    Monthly visitors increased 163% MoM.

  • Nov 11, 2025

    Monthly visitors increased 44% MoM.

AlgiSys BioSciences, Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

AlgiSys BioSciences, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about AlgiSys BioSciences, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersCleveland, Ohio
Employee Range8
Year Founded2009
Last FundingMay 21, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?